Biotechnology News

October 9, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Dr. Gavin Gordon, CollabRx Head of Business Development & Alliances, will participate in the annual conference of the Oregon Bioscience Association to be held on October 9th and 10th.

October 9, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince and Associates Clinical Research announced that Dr. Brad Vince recently shared his expertise at the American College of Clinical Pharmacology Annual Meeting in San Diego September 23.

October 9, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Laboratories Must Prepare for Increased Aspergillus Testing Demand in Wake of Fungal Meningitis Outbreak.

October 9, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has named Jane Wasman as President, International. Ms. Wasman most recently has served as Acorda’s Chief, Strategic Development and General Counsel....

October 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vaxxas, a biotechnology company with a novel vaccine-delivery platform that activates immunological cells immediately below the surface of the skin, appointed David Hoey as Chief Executive Officer.

October 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vaxxas announced the initiation of a research collaboration with Merck to evaluate Vaxxas’ proprietary Nanopatch™ platform that targets the abundant immunological cells below the surface of the skin.

October 9, 2012

CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), and MassDevelopment announced today that MassDevelopment has awarded InVivo Therapeutics a $2 million loan from its Emerging Technology Fund to help fund...

October 9, 2012

VIENNA--(BUSINESS WIRE)--As chair of the NGS analysis workflow optimization sessions at Bio-IT World Europe Conference & Expo, Aspera co-founder and president Michelle Munson will deliver opening remarks and present “High-Speed Data Movement...

October 9, 2012

HAYWARD, Calif. & LONDON--(BUSINESS WIRE)--Clinical data shows that the KineSpring System significantly reduces pain and improves functionality in knee osteoarthritis patients. Allows patients to delay full replacement knee surgery.

October 9, 2012

VIENNA--(BUSINESS WIRE)--Bio-IT World Europe Conference – GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) designed for today’s omics labs, unveiled Clarity LIMS, a revolutionary LIMS that...

October 9, 2012

FREISING, Germany--(BUSINESS WIRE)--Pieris Achieves First Milestone Payment in Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics

October 9, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics AB (STO:PREC) has successfully completed a rights issue with preferential rights which has supplied the Company with approximately SEK 54.4 million prior to issue costs. The rights...

October 9, 2012

LEIDEN, The Netherlands--(BUSINESS WIRE)--Leading cancer vaccine company DCPrime appoints CEO, CMO and expands board; DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types.

October 9, 2012

SAN DIEGO--(BUSINESS WIRE)--Medistem appointed Dr. Alan Lewis as CEO. Medistem's ERC Stem Cell is in clinical trials for heart failure and critical limb ischemia. Plans are underway for beginning Type 1 Diabetes trials.

October 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme to Present New Data from AUBAGIO® and LEMTRADA (TM) Clinical Development Programs at ECTRIMS

October 8, 2012

FARMINGTON HILLS, Mich.--(BUSINESS WIRE)--Scott Popyk, CEO of Health Dimensions Compounding Pharmacy stresses importance of its PCAB accreditation and recognition as CQI Center of Excellence by Dynalabs, an independent quality assurance lab.

October 8, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Rusch EZ-Blocker Endobronchial Blocker Receives 510(k) Clearance

October 8, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) announced today the results, as of 11:59 p.m., Eastern time, on October 5, 2012 (the “Consent Payment Deadline”), of the cash tender offer and consent solicitation (the “Tender...

October 8, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Paris:ALCLS) (Alternext: ALCLS), the French genome engineering specialist, considers the award of the Nobel Prize fin Medicine to Professor Shinya Yamanaka as the validation of its stem cell...

October 8, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announces the launch of the Blood Safety Innovation Award. The international award is designed to support scientific and clinical research to enable new advances in blood safety in hematology,...

October 8, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Black & Veatch was recently selected by the U.S. Defense Threat Reduction Agency (DTRA) to continue the company’s work in Ukraine to enhance the partner nation’s sustainable capacity to detect, diagnose,...

October 8, 2012

ZURICH & HAMBURG, Germany--(BUSINESS WIRE)--Partnering opened last week for BIO-Europe® international partnering conference in Hamburg, Germany November 12–14, 2012. The 18th annual event, organized by EBD Group, the leading partnering firm...

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceuticals issues, has released findings from the TreatmentTrends® Prostate Cancer (US) Q3 2012 report, in which...

October 8, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the fact that several leading brands are near the end of their patent...

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that over 60 percent of surveyed nephrologists in the United States expect to begin...

October 8, 2012

HARTFORD, Conn.--(BUSINESS WIRE)--Aetna announced it is expanding its integrated capabilities to offer Aetna’s disability customers and members a more simplified experience.

October 8, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Instantaneous microbial detection advances quality assurance techniques for drug compounding.

October 8, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT) today provided details of a previously announced workforce reduction that will affect approximately 38% of current employees. The company further announced that it will close...

October 8, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, October 25, 2012 at 9 a.m. ET to discuss the company’s third quarter 2012 financial and...

October 8, 2012

SOUTH SAN FRANCISCO, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)--Trellis Bioscience LLC (Trellis) and Open Monoclonal Technology, Inc. (OMT) today announced a new collaboration where the companies will join forces to generate human...

October 8, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a...

October 8, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena completes Phase 2a clinical study of TRV027 in advanced heart failure. TRV027 improved hemodynamics, was well tolerated, and preserved kidney function. TRV027 will advance to a trial in ADHF.

October 8, 2012

HYDERABAD, India--(BUSINESS WIRE)--The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE...

October 8, 2012

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Revance) today announced a settlement and termination agreement for its contractual relationships with Medicis Pharmaceutical Corporation (NYSE:MRX) concerning RT001 Botulinum Toxin...

October 8, 2012

GLEN BURNIE, Md.--(BUSINESS WIRE)--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery™. The full-service testing program is...

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB:FCSC), a biotechnology company focused on commercializing LAVIV, the first and only FDA-approved personalized cell therapy in aesthetic dermatology, and on developing innovative...

October 8, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO, will present a corporate update at the 11th Annual BIO Investor Forum hosted by the...

October 8, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announced the launch of its MediGuide Technology. The MediGuide technology allows physicians to reduce the duration of radiation exposure during cardiac procedures.

October 8, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has accepted an invitation and signed a formal...

October 8, 2012

BRUSSELS--(BUSINESS WIRE)--Delphi Genetics announces a licensing agreement with a subsidiary of Merck & Co.for the use of the StabyExpress technology,which allows high yield,cost effective protein expression without antibiotics

October 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--FDA extends by five years U.S. Patent No. 6,028,071, which covers FOLOTYN® (pralatrexate injection), postponing the original July 16, 2017 expiration date until July 16, 2022.

October 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) announced today there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of...

October 8, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--Digital health and emerging patient-friendly technologies the focus of Oregon Bio conference. "Bioscience Digitization and Discovery" features 45 world-renowned speakers, focus on STEM curriculum.

October 8, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics raised 2012 aggregate partner company revenue guidance to a range of $185 million to $190 million, representing an increase of 33% to 37% as compared to $139.2 million in 2011.

October 8, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of...

October 8, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics (NYSE:SFE) will host its 6th annual Investor Day 2012, which is being held at The Yale Club of New York City. WEBCAST available...